J. Fahlke

3.5k total citations · 1 hit paper
28 papers, 2.3k citations indexed

About

J. Fahlke is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, J. Fahlke has authored 28 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 14 papers in Surgery. Recurrent topics in J. Fahlke's work include Pancreatic and Hepatic Oncology Research (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). J. Fahlke is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Gastric Cancer Management and Outcomes (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). J. Fahlke collaborates with scholars based in Germany and Spain. J. Fahlke's co-authors include Karsten Ridwelski, E. Kettner, Stefan Post, H Schramm, Klaus Gellert, Hanno Riess, Carl Zuelke, Jan M. Langrehr, Helmut Oettle and Christof Burkart and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

J. Fahlke

23 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

2007 1.8k citations Helmut Oettle, Stefan Post et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Fahlke Germany	10	2.0k	943	924	690	543	28	2.3k
L. Roll Germany	4	1.7k 0.9×	736 0.8×	650 0.7×	665 1.0×	530 1.0×	8	1.9k
J. F. Seitz France	20	1.8k 0.9×	965 1.0×	843 0.9×	220 0.3×	361 0.7×	47	2.6k
Jens Stieler Germany	22	1.4k 0.7×	526 0.6×	523 0.6×	386 0.6×	532 1.0×	51	2.1k
Robert Marsh United States	24	2.0k 1.0×	1.1k 1.2×	1.0k 1.1×	462 0.7×	490 0.9×	78	2.5k
Axel Kleespies Germany	27	1.0k 0.5×	938 1.0×	610 0.7×	191 0.3×	259 0.5×	68	2.0k
Stefano Cordio Italy	17	1.8k 0.9×	888 0.9×	705 0.8×	187 0.3×	242 0.4×	74	2.1k
Jörg Fahlke Germany	9	1.3k 0.7×	732 0.8×	650 0.7×	394 0.6×	421 0.8×	21	1.6k
Jan‐Sing Hsieh Taiwan	25	912 0.5×	740 0.8×	697 0.8×	93 0.1×	375 0.7×	79	2.0k
Faysal Dane Türkiye	19	757 0.4×	303 0.3×	484 0.5×	237 0.3×	172 0.3×	131	1.3k
Knut Jørgen Labori Norway	24	1.2k 0.6×	697 0.7×	501 0.5×	323 0.5×	284 0.5×	102	1.6k

Countries citing papers authored by J. Fahlke

Since Specialization

Citations

This map shows the geographic impact of J. Fahlke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Fahlke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Fahlke more than expected).

Fields of papers citing papers by J. Fahlke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Fahlke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Fahlke. The network helps show where J. Fahlke may publish in the future.

Co-authorship network of co-authors of J. Fahlke

This figure shows the co-authorship network connecting the top 25 collaborators of J. Fahlke. A scholar is included among the top collaborators of J. Fahlke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Fahlke. J. Fahlke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fahlke, J., et al.. (2017). The risk of malnutrition in patients with a colon carcinoma: An analysis of 13239 patients.. Journal of Clinical Oncology. 35(15_suppl). e15057–e15057.

Ridwelski, Karsten, et al.. (2017). R1-Resektion beim Magenkarzinom. Der Chirurg. 88(9). 756–763. 9 indexed citations

Fahlke, J., et al.. (2017). The characteristics of c-MET and HER2 expression in gastric carcinoma and its correlation with clinical-pathological parameters.. Journal of Clinical Oncology. 35(15_suppl). e15566–e15566. 1 indexed citations

Fahlke, J., et al.. (2010). First-line therapy for advanced pancreatic cancer with gemcitabine and docetaxel versus gemcitabine and erlotinib: A multivariate matched pair analysis.. Journal of Clinical Oncology. 28(15_suppl). e14572–e14572. 2 indexed citations

Ignatov, Atanas, et al.. (2008). An 11-year retrospective study of totally implanted central venous access ports: Complications and patient satisfaction. European Journal of Surgical Oncology. 35(3). 241–246. 109 indexed citations

Ridwelski, Karsten, J. Fahlke, E. Kettner, et al.. (2008). Docetaxel-cisplatin (DC) versus 5-fluorouracil-leucovorin-cisplatin (FLC) as first-line treatment for locally advanced or metastatic gastric cancer: Preliminary results of a phase III study. Journal of Clinical Oncology. 26(15_suppl). 4512–4512. 15 indexed citations

Oettle, Helmut, Stefan Post, P. Neuhaus, et al.. (2007). Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer. JAMA. 297(3). 267–267. 1754 indexed citations breakdown →

Fahlke, J., Karsten Ridwelski, E. Kettner, et al.. (2007). A Multicentre Phase II Study of Docetaxel plus Cisplatin for the Treatment of Advanced Gastric Cancer. Chemotherapy. 53(6). 454–460. 6 indexed citations

Ridwelski, Karsten, J. Fahlke, Ralf Kühn, et al.. (2006). Multicenter phase-I/II study using a combination of gemcitabine and docetaxel in metastasized and unresectable, locally advanced pancreatic carcinoma. European Journal of Surgical Oncology. 32(3). 297–302. 10 indexed citations

10.

Fahlke, J., et al.. (2004). [Oncologic surgical procedures in ambulatory and brief inpatient surgery].. PubMed. 75(2). 144–52. 1 indexed citations

11.

Ridwelski, Karsten, E. Kettner, J. Fahlke, et al.. (2004). Phase I study of the anti-neovascular agent MBT-0206 to evaluate safety and efficacy in patients with metastatic or advanced unresectable gastrointestinal cancer (GI cancer). Journal of Clinical Oncology. 22(14_suppl). 3163–3163. 6 indexed citations

12.

Fahlke, J., et al.. (2002). Outpatient Therapy with Gemcitabine and Docetaxel for Gallbladder, Biliary, and Cholangio-Carcinomas. Investigational New Drugs. 20(3). 351–356. 63 indexed citations

13.

Ridwelski, Karsten, J. Fahlke, H. Kröning, et al.. (2001). Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer. Annals of Oncology. 12(1). 47–51. 136 indexed citations

14.

Fahlke, J., et al.. (2001). Randomised trial with or without amifostin to reduce neurotoxic side effects under chemotherapy with oxaliplatin (L-OHP), FA/-FU (Folfox 3). European Journal of Cancer. 37. S362–S362. 1 indexed citations

15.

Fahlke, J., et al.. (2001). Aneurysmaentwicklung und Spätruptur von retrograd perfundierten Iliakalarterien. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 126(12). 1009–1011.

16.

Tautenhahn, J., et al.. (2001). Simultaneous treatment of Salmonella typhimurium-induced symptomatic abdominal aortic aneurysm with associated spondylitis. VASA. 30(4). 293–296. 1 indexed citations

17.

Ridwelski, Karsten, et al.. (2001). Stellenwert von Cytokeratin- und CA19–9-Antigen im immunhistologischen Nachweis disseminierter Tumorzellen in Lymphknoten beim Pankreascarcinom. Der Chirurg. 72(8). 920–926. 12 indexed citations

18.

Fahlke, J., Karsten Ridwelski, & H. Lippert. (1999). High-dose therapy with combined 5-fluorouracil and folinic acid with and without amifostine in the treatment of patients with metastatic colorectal carcinoma. International Journal of Colorectal Disease. 14(2). 128–130. 19 indexed citations

19.

Manger, T., et al.. (1999). [Laparoscopic cholecystectomy. A recommendable indication in acute cholecystitis?].. PubMed. 124(12). 1121–9. 1 indexed citations

20.

Ridwelski, Karsten, et al.. (1998). [Locoregional and systemic therapy of advanced pancreatic carcinoma].. PubMed. 115. 1344–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact